NO993979D0 - FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor - Google Patents
FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derforInfo
- Publication number
- NO993979D0 NO993979D0 NO993979A NO993979A NO993979D0 NO 993979 D0 NO993979 D0 NO 993979D0 NO 993979 A NO993979 A NO 993979A NO 993979 A NO993979 A NO 993979A NO 993979 D0 NO993979 D0 NO 993979D0
- Authority
- NO
- Norway
- Prior art keywords
- alzheimer
- onset
- procedures
- disease
- delay
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/993,901 US5985936A (en) | 1997-12-18 | 1997-12-18 | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
PCT/CA1998/001147 WO1999032097A2 (en) | 1997-12-18 | 1998-12-18 | Phytosterol composition for preventing alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993979D0 true NO993979D0 (no) | 1999-08-18 |
NO993979L NO993979L (no) | 1999-10-13 |
Family
ID=25540052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993979A NO993979L (no) | 1997-12-18 | 1999-08-18 | FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor |
Country Status (18)
Country | Link |
---|---|
US (1) | US5985936A (no) |
EP (1) | EP0967982A2 (no) |
CN (1) | CN1252724A (no) |
AU (1) | AU1656099A (no) |
BG (1) | BG103740A (no) |
BR (1) | BR9807577A (no) |
CA (1) | CA2281710A1 (no) |
EE (1) | EE9900354A (no) |
GE (1) | GEP20022783B (no) |
HU (1) | HUP0100737A3 (no) |
LT (1) | LT4801B (no) |
LV (1) | LV12438B (no) |
MD (1) | MD1920F2 (no) |
NO (1) | NO993979L (no) |
PL (1) | PL335421A1 (no) |
RU (1) | RU2173151C2 (no) |
SK (1) | SK112999A3 (no) |
WO (1) | WO1999032097A2 (no) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060141036A1 (en) * | 1997-12-12 | 2006-06-29 | Andrx Labs Llc | HMG-CoA reductase inhibitor extended release formulation |
EP1225880A2 (en) * | 1999-11-04 | 2002-07-31 | Andrx Corporation | Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
WO2001078529A2 (en) | 2000-04-14 | 2001-10-25 | Mars, Incorporated | Compositions and methods for improving vascular health |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
US20030013692A1 (en) * | 2001-01-19 | 2003-01-16 | Gullans Steven R. | Methods of treating neurological disorders |
AU2002237847A1 (en) * | 2001-02-12 | 2002-08-28 | Akzo Nobel N.V | Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
DE10154221A1 (de) * | 2001-11-07 | 2003-05-15 | Max Delbrueck Centrum | Mittel zur Behandlung von Läsionen des Nervensystems |
FR2848452B1 (fr) * | 2002-12-12 | 2007-04-06 | Aventis Pharma Sa | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
JP5137228B2 (ja) | 2003-03-07 | 2013-02-06 | メルク・シャープ・アンド・ドーム・コーポレーション | 高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用 |
DE602004018617D1 (de) | 2003-03-07 | 2009-02-05 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
EP1606287B1 (en) * | 2003-03-07 | 2013-10-02 | Merck Sharp & Dohme Corp. | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
US20080182801A1 (en) * | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
GB0329667D0 (en) * | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
GB0513881D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
AU2005208566A1 (en) * | 2004-01-22 | 2005-08-11 | Genaissance Pharmaceuticals, Inc. | APOE genetic markers associated with age of onset of Alzheimer's Disease |
CA2587985C (en) * | 2004-11-24 | 2016-05-10 | Neopro Labs, Llc | Peptides for use in treatment in fever or pain |
GB0512726D0 (en) * | 2005-06-22 | 2005-07-27 | Btg Int Ltd | Multiple sclerosis therapy and diagnosis |
GB0513883D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Diagnosis of Atherosclerosis |
GB0513888D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
JP2011516417A (ja) * | 2008-03-27 | 2011-05-26 | エヴォテック・ノイロサイエンシーズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Nmdanr2b−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
WO2010104375A1 (en) | 2009-03-12 | 2010-09-16 | N.V. Nutricia | Stigmasterol for the treatment of alzheimer's disease |
US9011937B2 (en) | 2010-11-22 | 2015-04-21 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with extract of Nerium species or Thevetia species |
US10383886B2 (en) | 2010-01-11 | 2019-08-20 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with oleandrin |
US10307450B2 (en) | 2010-01-11 | 2019-06-04 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with extract of Nerium species or Thevetia species |
WO2012149111A1 (en) | 2011-04-26 | 2012-11-01 | The Regents Of The University Of California | Methods of promoting cns neuronal repair by inhibiting lrp-1 |
CN102813659A (zh) * | 2012-08-21 | 2012-12-12 | 贵阳中医学院 | 20α-二甲胺基- 2α-羟基-3β-惕洛酰胺基-5α-孕甾烷的用途 |
WO2015123618A1 (en) * | 2014-02-14 | 2015-08-20 | Arizona Board Of Regents For The University Of Arizona | Method for increasing bcl2 gene expression |
US10702567B2 (en) | 2016-09-14 | 2020-07-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infection |
US10596186B2 (en) | 2016-09-14 | 2020-03-24 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infections |
US11331291B2 (en) | 2017-09-14 | 2022-05-17 | Phoenix Biotechnology, Inc. | Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders |
MX2020002884A (es) | 2017-09-14 | 2020-10-05 | Phoenix Biotechnology Inc | Método y composición neuroprotectora mejorada para tratar afecciones neurológicas. |
EP4081198A1 (en) | 2019-12-24 | 2022-11-02 | Folium Biosciences Europe B.V. | Food supplement for alzheimer |
EP3842039A1 (en) * | 2019-12-24 | 2021-06-30 | Folium Biosciences Europe B.V. | Food supplement comprising cannbinoids and phytosterols for alzheimer |
US11806359B2 (en) | 2020-03-31 | 2023-11-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating Coronavirus infection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1203515B (it) * | 1987-02-26 | 1989-02-15 | Indena Spa | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono |
AU6274394A (en) * | 1993-02-23 | 1994-09-14 | Pharmakon Usa, Inc. | Therapeutic herbal composition |
US5589182A (en) * | 1993-12-06 | 1996-12-31 | Tashiro; Renki | Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression |
DK1707572T3 (da) * | 1994-09-29 | 2014-05-12 | Univ British Columbia | Sterolsammensætninger fra papirmassesæbe |
CN1179903A (zh) * | 1996-10-09 | 1998-04-29 | 李辉 | 营养丝米粉 |
DK1019044T3 (da) * | 1997-05-15 | 2007-08-06 | Univ Washington | Præparat og fremgangsmåder til behandling af Alzheimers sygdom og andre amyloidoser |
-
1997
- 1997-12-18 US US08/993,901 patent/US5985936A/en not_active Expired - Fee Related
-
1998
- 1998-12-18 AU AU16560/99A patent/AU1656099A/en not_active Abandoned
- 1998-12-18 PL PL98335421A patent/PL335421A1/xx unknown
- 1998-12-18 EP EP98960959A patent/EP0967982A2/en not_active Ceased
- 1998-12-18 RU RU99120072/14A patent/RU2173151C2/ru not_active IP Right Cessation
- 1998-12-18 GE GEAP19984990A patent/GEP20022783B/en unknown
- 1998-12-18 HU HU0100737A patent/HUP0100737A3/hu unknown
- 1998-12-18 CN CN98804259A patent/CN1252724A/zh active Pending
- 1998-12-18 CA CA002281710A patent/CA2281710A1/en not_active Abandoned
- 1998-12-18 BR BR9807577-2A patent/BR9807577A/pt not_active IP Right Cessation
- 1998-12-18 WO PCT/CA1998/001147 patent/WO1999032097A2/en not_active Application Discontinuation
- 1998-12-18 EE EEP199900354A patent/EE9900354A/xx unknown
- 1998-12-18 SK SK1129-99A patent/SK112999A3/sk unknown
- 1998-12-18 MD MD99-0262A patent/MD1920F2/ro unknown
-
1999
- 1999-08-18 NO NO993979A patent/NO993979L/no not_active Application Discontinuation
- 1999-09-16 LT LT1999114A patent/LT4801B/lt not_active IP Right Cessation
- 1999-09-17 BG BG103740A patent/BG103740A/xx unknown
- 1999-09-17 LV LVP-99-134A patent/LV12438B/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0100737A3 (en) | 2002-07-29 |
EE9900354A (et) | 2000-02-15 |
WO1999032097A2 (en) | 1999-07-01 |
NO993979L (no) | 1999-10-13 |
BG103740A (en) | 2000-05-31 |
RU2173151C2 (ru) | 2001-09-10 |
CN1252724A (zh) | 2000-05-10 |
LT4801B (lt) | 2001-06-25 |
EP0967982A2 (en) | 2000-01-05 |
WO1999032097A3 (en) | 1999-09-02 |
HUP0100737A2 (hu) | 2001-09-28 |
GEP20022783B (en) | 2002-09-25 |
CA2281710A1 (en) | 1999-07-01 |
MD1920F2 (ro) | 2002-05-31 |
LV12438A (en) | 2000-03-20 |
AU1656099A (en) | 1999-07-12 |
LV12438B (en) | 2000-09-20 |
SK112999A3 (en) | 2001-11-06 |
LT99114A (lt) | 2001-01-25 |
PL335421A1 (en) | 2000-04-25 |
BR9807577A (pt) | 2001-08-07 |
MD990262A (en) | 2000-06-30 |
US5985936A (en) | 1999-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO993979D0 (no) | FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor | |
CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
NO994014D0 (no) | Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer | |
DK1041990T3 (da) | Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin | |
EE04390B1 (et) | Paikne preparaat dermatoloogiliste seisundite raviks | |
PT1083889E (pt) | Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas | |
ID28947A (id) | Metode untuk meringankan inkontinensia uriner wanita | |
NO972972L (no) | Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse | |
IS5405A (is) | Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir | |
ID29198A (id) | Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paru | |
BR9800344A (pt) | Composição de vidro e utilização das composições de vidro | |
PT907364E (pt) | Composicao farmaceutica de libertacao sustida | |
EE9900036A (et) | Uued ühendid ja kompositsioonid trüptaasi aktiivsusega seotud haiguste raviks | |
NO981388L (no) | Bedring av Dupuytrens sykdom | |
FI953915A (fi) | Dupuytrenin taudin lievittämiseen | |
GB9720797D0 (en) | Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome | |
BR9711225A (pt) | Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer | |
NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
IL121096A0 (en) | Pharmaceutical compositions for the treatment of liver disease | |
FR2786096B1 (fr) | Composition pour la prevention et le traitement topique de la cellulite | |
GB9708067D0 (en) | Rapid and long lasting biocidal system and its use to the treatment of hard surfaces | |
ID21769A (id) | Komposisi-komposisi cangkokan hasil kopolimerisasi | |
HUP0103960A2 (hu) | A terápiás fehérjékre adott immunválasz erősségének csökkentésére szolgáló eljárások | |
NO970127D0 (no) | Topiske sammensetninger for behandling av hudsykdom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |